Esperion Therapeutics ESPR Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Esperion Therapeutics (ESPR) reported comprehensive income (loss), net of tax, attributable to parent of -$25.2M in Q1 2026.
- How has Esperion Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Esperion Therapeutics's comprehensive income (loss), net of tax, attributable to parent increased by 37.7% year-over-year, from -$40.46M to -$25.2M.
- What is the long-term trend for Esperion Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 3 years (2021 to 2024), Esperion Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a -42.3% compound annual growth rate (CAGR), from -$269.14M to -$51.75M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric reflects the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as foreign currency translation adjustments or unrealized gains and losses on certain investments. It provides a broader view of financial performance beyond traditional net income by capturing volatility in equity that does not stem from capital transactions. Investors use this to evaluate the total impact of external market factors and accounting adjustments on the company's overall financial position.